Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. 1994

J R Vane, and J A Mitchell, and I Appleton, and A Tomlinson, and D Bishop-Bailey, and J Croxtall, and D A Willoughby
William Harvey Research Institute, St. Bartholomew's Hospital Medical College, London, United Kingdom.

Cyclooxygenase (COX) converts arachidonic acid to prostaglandin H2, which is further metabolized to prostanoids. Two isoforms of COX exist: a constitutive (COX-1) and an inducible (COX-2) enzyme. Nitric oxide is derived from L-arginine by isoforms of nitric-oxide synthase (NOS; EC 1.14.13.39): constitutive (cNOS; calcium-dependent) and inducible (iNOS; calcium-independent). Here we have investigated inducible isoforms of COX and NOS in the acute, chronic, and resolving stages of a murine air pouch model of granulomatous inflammation. COX and NOS activities were measured in skin samples in the acute phase, up to 24 h. Activities in granulomatous tissue were measured at 3, 5, 7, 14, and 21 days for the chronic and resolving stages of inflammation. COX-1 and COX-2 proteins were assessed by Western blot. COX activity in the skin increased over the first 24 h and continued to rise up to day 14. COX-2 protein rose progressively, also peaking at day 14. COX-1 protein remained unaltered throughout. The iNOS activity increased over the first 24 h in the skin, with a further major increase in the granulomatous tissue between days 3 and 7, followed by a decrease at day 14 and a further increase at day 21. The rise in COX and NOS activities in the skin during the acute phase reinforces the proinflammatory role for prostanoids and suggests one also for nitric oxide. However, in the chronic and resolving stages, a dissociation of COX and NOS activity occurred. Thus, there may be differential regulation of these enzymes, perhaps due to the changing pattern of cytokines during the inflammatory response.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D011451 Prostaglandin-Endoperoxide Synthases Enzyme complexes that catalyze the formation of PROSTAGLANDINS from the appropriate unsaturated FATTY ACIDS, molecular OXYGEN, and a reduced acceptor. Fatty Acid Cyclo-Oxygenase,PGH Synthase,Prostaglandin H Synthase,Prostaglandin Synthase,Prostaglandin-Endoperoxide Synthase,Arachidonic Acid Cyclooxygenase,Cyclo-Oxygenase,Cyclooxygenase,Cyclooxygenases,Hydroperoxide Cyclase,PGH2 Synthetase,Prostaglandin Cyclo-Oxygenase,Prostaglandin Cyclooxygenase,Prostaglandin Endoperoxide Synthetase,Prostaglandin G-H Synthase,Prostaglandin H2 Synthetase,Prostaglandin Synthetase,Cyclase, Hydroperoxide,Cyclo Oxygenase,Cyclo-Oxygenase, Fatty Acid,Cyclo-Oxygenase, Prostaglandin,Cyclooxygenase, Arachidonic Acid,Cyclooxygenase, Prostaglandin,Endoperoxide Synthetase, Prostaglandin,Fatty Acid Cyclo Oxygenase,G-H Synthase, Prostaglandin,Prostaglandin Cyclo Oxygenase,Prostaglandin Endoperoxide Synthases,Prostaglandin G H Synthase,Synthase, PGH,Synthase, Prostaglandin,Synthase, Prostaglandin G-H,Synthase, Prostaglandin H,Synthase, Prostaglandin-Endoperoxide,Synthases, Prostaglandin-Endoperoxide,Synthetase, PGH2,Synthetase, Prostaglandin,Synthetase, Prostaglandin Endoperoxide,Synthetase, Prostaglandin H2
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D005260 Female Females
D006099 Granuloma A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents. Granulomas
D000594 Amino Acid Oxidoreductases A class of enzymes that catalyze oxidation-reduction reactions of amino acids. Acid Oxidoreductases, Amino,Oxidoreductases, Amino Acid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease

Related Publications

J R Vane, and J A Mitchell, and I Appleton, and A Tomlinson, and D Bishop-Bailey, and J Croxtall, and D A Willoughby
January 1995, Advances in pharmacology (San Diego, Calif.),
J R Vane, and J A Mitchell, and I Appleton, and A Tomlinson, and D Bishop-Bailey, and J Croxtall, and D A Willoughby
January 1998, Expert opinion on investigational drugs,
J R Vane, and J A Mitchell, and I Appleton, and A Tomlinson, and D Bishop-Bailey, and J Croxtall, and D A Willoughby
October 1995, The Histochemical journal,
J R Vane, and J A Mitchell, and I Appleton, and A Tomlinson, and D Bishop-Bailey, and J Croxtall, and D A Willoughby
August 1993, Journal of leukocyte biology,
J R Vane, and J A Mitchell, and I Appleton, and A Tomlinson, and D Bishop-Bailey, and J Croxtall, and D A Willoughby
December 2002, Animal health research reviews,
J R Vane, and J A Mitchell, and I Appleton, and A Tomlinson, and D Bishop-Bailey, and J Croxtall, and D A Willoughby
January 1998, Biochemical pharmacology,
J R Vane, and J A Mitchell, and I Appleton, and A Tomlinson, and D Bishop-Bailey, and J Croxtall, and D A Willoughby
January 1997, The Journal of biological chemistry,
J R Vane, and J A Mitchell, and I Appleton, and A Tomlinson, and D Bishop-Bailey, and J Croxtall, and D A Willoughby
September 2003, Cancer letters,
J R Vane, and J A Mitchell, and I Appleton, and A Tomlinson, and D Bishop-Bailey, and J Croxtall, and D A Willoughby
January 2000, Immunologic research,
J R Vane, and J A Mitchell, and I Appleton, and A Tomlinson, and D Bishop-Bailey, and J Croxtall, and D A Willoughby
August 2002, Journal of gastroenterology and hepatology,
Copied contents to your clipboard!